Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BIOSTEEL A/S

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.4% 1.4%   Bankruptcy risk   1.3% 1.0% 1.0% 14.2% 2.3% 1.6% 6.5% 6.4%   Credit score (0-100)   82 87 85 14 64 71 12 12   Credit rating   BBB A A B BBB BBB BB BB   Credit limit (kDKK)   131.9 711.3 465.8 0.0 0.1 9.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   4,185 5,483 5,027 344 2,881 2,111 0.0 0.0   EBITDA   2,252 4,079 3,076 -1,662 1,943 879 0.0 0.0   EBIT   2,167 4,064 3,064 -1,673 1,939 875 0.0 0.0   Pre-tax profit (PTP)   2,176.7 4,082.0 3,001.0 -1,783.9 1,785.3 776.4 0.0 0.0   Net earnings   1,696.5 3,180.5 2,338.6 -1,394.9 1,391.5 604.1 0.0 0.0   Pre-tax profit without non-rec. items   2,177 4,082 3,001 -1,784 1,785 776 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   603 340 328 316 313 309 0.0 0.0   Shareholders equity total   5,123 7,304 5,642 1,248 1,891 2,496 1,688 1,688   Interest-bearing liabilities   293 322 56.4 3,529 1,899 757 0.0 0.0   Balance sheet total (assets)   6,553 9,629 7,701 13,096 7,381 5,511 1,688 1,688   Net Debt   -5,139 -5,457 -2,544 1,964 1,445 452 -1,688 -1,688     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   4,185 5,483 5,027 344 2,881 2,111 0.0 0.0   Gross profit growth   -7.7% 31.0% -8.3% -93.1% 736.6% -26.7% -100.0% 0.0%   Employees   3 2 2 3 1 2 0 0   Employee growth %   0.0% -33.3% 0.0% 50.0% -66.7% 100.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   6,553 9,629 7,701 13,096 7,381 5,511 1,688 1,688   Balance sheet change%   -1.0% 46.9% -20.0% 70.1% -43.6% -25.3% -69.4% 0.0%   Added value   2,252.5 4,078.7 3,076.1 -1,661.9 1,950.5 878.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   186 -278 -25 -22 -7 -7 -309 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 -1.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   51.8% 74.1% 60.9% -485.8% 67.3% 41.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   33.4% 50.9% 35.7% -16.0% 19.0% 14.4% 0.0% 0.0%   ROI %   39.9% 63.2% 46.4% -31.8% 45.5% 26.3% 0.0% 0.0%   ROE %   35.5% 51.2% 36.1% -40.5% 88.7% 27.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   78.2% 75.8% 73.3% 9.5% 25.6% 45.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -228.2% -133.8% -82.7% -118.2% 74.4% 51.5% 0.0% 0.0%   Gearing %   5.7% 4.4% 1.0% 282.9% 100.4% 30.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.5% 12.0% 46.7% 6.7% 6.0% 11.4% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   4.0 3.6 3.3 0.9 0.9 1.5 0.0 0.0   Current Ratio   4.2 4.0 3.6 1.1 1.3 1.7 0.0 0.0   Cash and cash equivalent   5,432.2 5,778.4 2,600.5 1,564.4 453.5 304.3 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   4,520.3 6,963.9 5,314.8 931.1 1,578.6 2,186.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   751 2,039 1,538 -554 1,951 439 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   751 2,039 1,538 -554 1,943 439 0 0   EBIT / employee   722 2,032 1,532 -558 1,939 438 0 0   Net earnings / employee   566 1,590 1,169 -465 1,391 302 0 0